Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Allen R. Hilgers is active.

Publication


Featured researches published by Allen R. Hilgers.


Pharmaceutical Research | 1990

Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa

Allen R. Hilgers; Robert A. Conradi; Philip S. Burton

Human colon adenocarcinoma (Caco-2) cells, when grown on semipermeable filters, spontaneously differentiate in culture to form confluent monolayers which both structurally and functionally resemble the small intestinal epithelium. Because of this property they show promise as a simple, in vitro model for the study of drug absorption and metabolism during absorption in the intestinal mucosa. In the present study, the transport of several model solutes across Caco-2 cell monolayers grown in the Transwell ™ diffusion cell system was examined. Maximum transport rates were found for the actively transported substance glucose and the lipophilic solutes testosterone and salicylic acid. Slower rates were observed for urea, hippurate, and salicylate anions and were correlated with the apparent partition coefficient of the solute. These results are similar to what is found with the same compounds in other, in vivo absorption model systems. It is concluded that the Caco-2 cell system may give useful predictions concerning the oral absorption potential of new drug substances.


Pharmaceutical Research | 1991

The Influence of Peptide Structure on Transport Across Caco-2 Cells

Robert A. Conradi; Allen R. Hilgers; Norman F.H. Ho; Philip S. Burton

The relationship between structure and permeability of peptides across epithelial cells was studied. Using confluent monolayers of Caco-2 cells as a model of the intestinal epithelium, permeability coefficients were obtained from the steady-state flux of a series of neutral and zwitterionic peptides prepared from D-phenylalanine and glycine. Although these peptides ranged in lipophilicity (log octanol/water partition coefficient) from −2.2 to +2.8, no correlation was found between the observed flux and the apparent lipophilicity. However, a strong correlation was found for the flux of the neutral series and the total number of hydrogen bonds the peptide could potentially make with water. These results suggest that a major impediment to peptide passive absorption is the energy required to break water–peptide hydrogen bonds in order for the solute to enter the cell membrane. This energy appears not to be offset by the favorable introduction of lipophilic side chains in the amino acid residues.


Journal of Controlled Release | 1992

The relationship between peptide structure and transport across epithelial cell monolayers

Philip S. Burton; Robert A. Conradi; Allen R. Hilgers; Norman F.H. Ho; Linda L. Maggiora

Abstract The successful development of orally bioavailable peptides and peptide-like substances as therapeutic agents will require an understanding of how structure influences absorption across the intestinal mucosa. In an attempt to define such relationships, homologous series of peptides were prepared which varied in lipophilicity, chain length and number of polar functionalities, and permeability studies conducted across Caco-2 cell monolayers as a model of the intestinal mucosa. The results suggested that the number of polar groups in the peptide, which presumably require desolvation before transfer of the peptide into the cell membrane, was a principal determinant of transport. Consistent with this hypothesis, two experimental methods of determining desolvation potential were found to correlate well with the observed permeability results for the peptides. The insights gained from these studies were used in an attempt to rationally modify a renin inhibitory peptide, in order to improve its permeability across the intestinal mucosa. Based on the results of this work, it is argued that a peptide must possess a delicate balance of affinity for the aqueous-membrane interface and a reasonably low desolvation energy in order for it to efficiently cross an epithelial cell membrane.


Advanced Drug Delivery Reviews | 1991

(B) Mechanisms of peptide and protein absorption: (2) Transcellular mechanism of peptide and protein absorption: passive aspects

Philip S. Burton; Robert A. Conradi; Allen R. Hilgers

Abstract A major factor contributing to the poor bioavailability of peptides and proteins after non-parenteral administration is thought to be inefficient transport across cellular barriers. While the transport barrier for less functionalized drugs has been successfully modeled as a homogeneous octanol-like phase, peptide transport results do not fit this model. In this article we reexamine the literature on peptide transport, the architecture of biological membranes and peptide-lipid interactions. Based on these considerations, it is suggested that more realistic models, which incorporate the non-homogeneous nature of real biological membranes, provide a better basis for understanding the transport potential of highly functionalized molecules such as peptides and proteins.


Pharmaceutical Research | 2003

Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents.

Allen R. Hilgers; Donald P. Smith; John J. Biermacher; Jeffrey S. Day; Jana L. Jensen; Sandra M. Sims; Wade J. Adams; Janice M. Friis; Joe Palandra; John D. Hosley; Eric M. Shobe; Philip S. Burton

AbstractPurpose. The purpose of this work was to evaluate an oral absorption prediction model, maximum absorbable dose (MAD), which predicts a theoretical dose of drug that could be absorbed across rat intestine based on consideration of intestinal permeability, solute solubility, intestinal volume, and residence time. Methods. In the present study, Caco-2 cell permeability, as a surrogate for rat intestinal permeability, and aqueous solubility were measured for 27 oxazolidinones. The oxazolidinones are a novel class of potential antibacterial agents currently under investigation. These values were used to estimate MAD for each of the compounds. Finally, these predicted values were compared to previously measured bioavailability data in the rat in order to estimate oral absorption properties. Results. A reasonably good correlation between predicted dose absorbed and bioavailability was observed for most of the compounds. In a few cases involving relatively insoluble compounds, absorption was underestimated. For these compounds while aqueous solubility was low, solubility in 5% polysorbate 80 was significantly higher, a solvent possibly more representative of the small intestinal lumen. Conclusions. These results suggest that MAD may be useful for prioritizing early discovery candidates with respect to oral absorption potential. In the case of compounds with poor aqueous solubility, additional factors may have to be considered such as solubility in the intestinal lumen.


Advanced Drug Delivery Reviews | 1997

In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption

Philip S. Burton; Jay T. Goodwin; Robert A. Conradi; Norman F.H. Ho; Allen R. Hilgers

Abstract Cellular efflux pathways function to remove both endogenous and exogenous substances from the cell. In the case of a polarized cellular barrier, such as the epithelium, these pathways serve an excretory or secretory role in transporting solutes out of tissue. Although well recognized in organs typically associated with drug excretion such as liver and kidney, similar transport pathways have been found in other tissues including the intestinal mucosa and the endothelial cells comprising the blood-brain barrier. Current evidence suggests that these systems may act as barriers to drug absorption into the tissues in which they are found. More recent studies have shown that hydrophobic peptides such as cyclosporin A are substrates for polarized efflux. In this review we examine the evidence for these mechanisms as absorption barriers and the use of in vitro transport models for characterizing this phenomenon. The presence of such pathways may help explain the poor membrane permeability of peptides which, along with metabolism, contributes to their poor in vivo performance.


Journal of Drug Targeting | 1994

Epithelial cell permeability of a series of peptidic HIV protease inhibitors: Aminoterminal substituent effects

Robert A. Conradi; Allen R. Hilgers; Philip S. Burton; Jackson B. Hester

The influence of the aminoterminal substituent in a homologous series of tetrapeptide analogs on transport across Caco-2 cell monolayers was studied. In a series of pyridylcarboxamide regioisomers, the 2-pyridyl isomer was significantly more permeable than either the 3- or 4-congeners. The uniqueness of this peptide was further suggested by examining the partitioning behavior between heptane and ethylene glycol, a system which has been developed as a simple estimate of the desolvation energy or hydrogen bonding potential of a peptide. In this model, the 2-isomer has a much larger partition coefficient than either the 3- or 4-analogs, consistent with its being less solvated than expected based on simple structural considerations. Factors possibly contributing to this decreased effective polarity could be steric interactions or intramolecular hydrogen bonding.


Journal of Pharmaceutical Sciences | 1996

How structural features influence the biomembrane permeability of peptides.

Philip S. Burton; Robert A. Conradi; Norman F.H. Ho; Allen R. Hilgers; Ronald T. Borchardt


Pharmaceutical Research | 1993

In Vitro/in Vivo Models for Peptide Oral Absorption: Comparison of Caco-2 Cell Permeability with Rat Intestinal Absorption of Renin Inhibitory Peptides

Robert A. Conradi; Karen F. Wilkinson; Bob D. Rush; Allen R. Hilgers; Mary J. Ruwart; Philip S. Burton


Quantitative Structure-activity Relationships | 1994

A Non-aqueous Partitioning System for Predicting the Oral Absorption Potential of Peptides

D. Andrew Paterson; Robert A. Conradi; Allen R. Hilgers; Thomas J. Vidmar; Philip S. Burton

Collaboration


Dive into the Allen R. Hilgers's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge